Literature DB >> 23248504

Significance of the carboxyhemoglobin level for out-of-hospital cardiopulmonary arrest.

Youichi Yanagawa1.   

Abstract

BACKGROUND: At low concentrations, carbon monoxide (CO) can confer cyto and tissue-protective effects, such as endogenous Heme oxygenase 1 expression, which has antioxidative, anti-inflammatory, antiproliferative, and antiapoptotic effects. The level of carboxyhemoglobin in the blood is an indicator of the endogenous production of CO and inhaled CO.
AIM OF STUDY: To investigate the significance of the value of carboxyhemoglobin for out-of-hospital (OH) cardiopulmonary arrest (CPA).
MATERIALS AND METHODS: This study involved a medical chart review of cases treated from January to December 2005. The inclusion criteria included a patient who was transported to this department due to an OH CPA. The exclusion criteria included a patient who did not undergo blood gas analysis on arrival and who experienced CPA due to acute carbon monoxide intoxication. The subjects were divided into two groups based on their final outcome of either survival or non-survival.
RESULTS: There was no significant difference associated with the sex, age, frequency of witness collapse, bystander cardiopulmonary arrest, electrocardiogram at scene, cause of CPA, value of PCO(2), HCO(3) (-), and methemoglobin. The frequency of OH return of spontaneous circulation and the value of pH, PO(2), base excess, and carboxyhemoglobin in the survival group were greater than those values in the non-survival group. There were no subjects whose carboxyhemoglobin level was 0% on arrival in the survival groups.
CONCLUSION: There appeared to be an association between higher carboxyhemoglobin levels and survival in comparison with non-survival patients.

Entities:  

Keywords:  Carbon monoxide; carboxyhemoglobin; cardiopulmonary arrest; outcome

Year:  2012        PMID: 23248504      PMCID: PMC3519048          DOI: 10.4103/0974-2700.102405

Source DB:  PubMed          Journal:  J Emerg Trauma Shock        ISSN: 0974-2700


INTRODUCTION

Out-of-hospital cardiopulmonary arrest (OHCPA) is a devastating disease process with neurological injury accounting for a disproportionate amount of the morbidity and mortality following the return of spontaneous circulation (ROSC).[1] The neurological injury is caused by a direct ischemic insult and a global cerebral ischemia-reperfusion injury following successful resuscitation from OHCPA. The global cerebral ischemia-reperfusion injury is induced by an inflammatory response, increased intracellular levels of glutamate, an excitatory neurotransmitter released from presynaptic terminals, activation of ion-channel complexes that cause calcium to shift from the extracellular to the intracellular fluid, leading to the accumulation of oxygen free radicals and the activation of degradative enzymes.[12] The global cerebral ischemia-reperfusion injury also induces the expression of Heme oxygenase 1 (HO-1).[3] The HO-1, a ubiquitous inducible stress-response protein, serves a major metabolic function in heme turnover. HO-1 activity cleaves heme to form biliverdin-IX, endogenous carbon monoxide (CO), and iron, which play a concerted action in cytoprotection against oxidative stress and in the modulation of cell proliferation and differentiation.[45] At low concentrations, exogenous CO can confer cyto and tissue-protective effects similar to those associated with endogenous HO-1 expression, including antioxidative, anti-inflammatory, antiproliferative, and antiapoptotic effects.[6] Experimentally, CO can ameliorate ischemia-reperfusion injury in neurons, the heart, lung, kidney, liver, small intestine and limbs.[6-12] In addition, blood carboxyhemoglobin is an indicator of the endogenous production of CO by the HO-1 and exogenous inhaled CO.[13] However, no study has investigated the carboxyhemoglobin level associated with cardiopulmonary arrest (CPA). Therefore, this study retrospectively investigated the significance of the level of carboxyhemoglobin following an OHCPA.

MATERIALS AND METHODS

This study was a retrospective chart analysis and it was approved by the Institutional Review Board in National Defense Medical College Hospital. This hospital has been able to analyze blood carboxyhemoglobin and methemoglobin levels using a blood gas analyzer (ABL 520 RadiometerR, Copenhagen, Denmark) since 2005 because this machine automatically measured the pH, PO2, PCO2, HCO3- , base excess (BE), carboxyhemoglobin, and methemoglobin. This study conducted a medical chart review of patients treated from January 2005 to December 2005. The inclusion criteria included patients who were transported to this department due to OHCPA. The exclusion criteria included patients who did not undergo blood gas analysis on arrival and those that experienced OHCPA due to acute carbon monoxide intoxication by carbon monoxide exposure. The subjects were divided into two groups based on their final outcome as survival or non-survival. The following variables measured at the time of the patients arrival were analyzed by a review of medical charts in the two groups: sex; age; witness of collapse; bystander cardiopulmonary resuscitation (CPR); electrocardiogram at scene (ventricular fibrillation (Vf) or not); cause of CPA (trauma or non trauma); state on arrival (out of hospital ROSC: OH-ROSC or CPA on arrival CPAOA); total ROSC; pH; PO2; PCO2: HCO3-; base excess (BE); carboxyhemoglobin and methemoglobin on arrival. A statistical analysis was performed using Student's unpaired t-test and the chi-squared test. Differences with P values of less than 0.05 were considered to be statistically significant.

RESULTS

There were 183 patients who were transported to this department due to OHCPA in 2005. Among them, 55 patients, who did not undergo blood gas analysis, were excluded. In addition, three patients who experienced cardiac arrest due to acute carbon monoxide intoxication were also excluded. The remaining 125 patients were defined as subjects in this study. All subjects underwent 10 L/minute of oxygen mask in prehospital setting and tracheal intubation after arrival with the same 10 L/minute of oxygen when a blood gas analysis was performed. The results of the groups defined by survival are shown in Table 1. There was no significant difference associated with the sex, age, frequency of witness collapse, bystander cardiopulmonary arrest, electrocardiogram at scene, cause of CPA, value of PCO2, HCO3-, and methemoglobin. The frequency of the OH ROSC and the value of pH, PO2, BE, and carboxyhemoglobin in the survival group were greater than those values in the non-survival group. There were no subjects whose carboxyhemoglobin level was 0% on arrival in the survival groups.
Table 1

Results based on the survival and non-survival

The value of carboxyhemoglobin was 54%, 55%, and 69% in the three excluded acute carbon monoxide intoxication cases. Two of those (54 and 69%) could not obtain ROSC and the other did not survive more than 24 hours after obtaining ROSC. Results based on the survival and non-survival

DISCUSSION

This is the first report that there appeared to be an association between higher carboxyhemoglobin levels and survival in comparison with the non-survival patients. The level of carboxyhemoglobin at the time of arrival in the emergency room might be important prognostic factor for predicting outcome of OHCPA. CPA induces a direct ischemic insult and ischemia-reperfusion injury occurs throughout the body after patients achieve ROSC. Endogenous or exogenous CO can ameliorate ischemia-reperfusion injury in multiple organs.[6-12] The level of blood carboxyhemoglobin has been shown to correlate with the endogenous and exogenous CO levels.[13] Carboxyhemoglobin levels as low as 2% to 6% decrease exercise capacity and induces ischemic ST-segment changes and arrhythmia.[1415] A previous study also demonstrated that the value of carboxyhemoglobin is associated with increased mortality among critically ill patients, so that failure to up-regulate the response in the proinflammatory stress phase is deleterious.[13] Therefore, the level of carboxyhemoglobin in OHCPA patients on arrival could be a prognostic factor. The optimal range for carboxyhemoglobin levels is a clinically important problem. A high level of carboxyhemoglobin, such as acute carbon monoxide intoxication, is lethal. Levels as low as 0.6% to 1.8% may be optimal to allow critically ill patients to survive in the intensive care unit.[13] None of the patients with a carboxyhemoglobin level of 0%, survived or regained consciousness in this study, indicating that 0% carboxyhemoglobin was not optimal value for OHCPA patients to obtain full recovery. While an average value of 1.85% carboxyhemoglobin in the survival group may already have deleterious side effects on the coronary and cerebral functions. Never smokers with a carboxyhemoglobin level in the top quartile (above 0.67%) had a significantly higher incidence of cardiac events and deaths, compared to those with carboxyhemoglobin levels in the lowest quartile (below 0.50%).[16] In addition, according to a multivariate analysis, the carboxyhemoglobin concentration was found to be the only independent predictor of carotid intima-media thickness so that chronic CO exposure may increase the risk of atherosclerotic cardiovascular events.[17] On the contrary, after establishing a cerebral ischemic model using mice by transient middle cerebral artery occlusion and exposing them to different concentrations of CO, Zeynalov demonstrated that low CO levels protected the brain from injury following 90-min transient focal ischemia and 48 h of reperfusion. One explanation for the CO protection in an ischemia-reperfusion protocol was that when CO is given at an early time point, it might limit the surge in free-radical formation following reperfusion.[18] Accordingly, chronic exposure of CO may be increase of ischemic event due to atherosclerotic change even in low concentration of CO. However, when this ischemic event occurs, then a low concentration of CO could work as protective against ischemia-reperfusion injury through anti-free-radical, anti-inflammatory, anti-apoptotic, and vasodilatory mechanism.[1920] Regarding some limitations of this study, we did not assess the smoking status of the subjects because that information was not in the medical records. The carboxyhemoglobin level is a biomarker for cigarette use.[21] The half-life of exogenously delivered CO without supplemental oxygen administration is 5-6 hour.[21] Accordingly, both exogenous (CO inhalation by cigarette use) and endogenous (CO production by HO-1) CO affected the level of carboxyhemoglobin in this study. The pH and BE levels as determined by a blood gas analysis might therefore be more informative factors regarding the prognosis because the smoking history was not found to influence the pH and BE levels.[22] Another limitation is due to the fact that this study was retrospective and it only had a small sample size of the survival group. Hence, further prospective large studies are needed to determine whether the carboxyhemoglobin level can be a prognostic tool in the emergency department or not, while also determining the optimal carboxyhemoglobin levels for OHCPA patients.

CONCLUSION

There appeared to be an association between higher carboxyhemoglobin levels and survival in comparisons with survival and non-survival patients.
  22 in total

Review 1.  Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke.

Authors:  Gerhard Scherer
Journal:  Exp Toxicol Pathol       Date:  2006-09-14

Review 2.  Carbon monoxide as an endogenous vascular modulator.

Authors:  Charles W Leffler; Helena Parfenova; Jonathan H Jaggar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-04-15       Impact factor: 4.733

3.  [Carbon monoxide inhalation protects against limb ischemia/reperfusion injury].

Authors:  Jing Li; Zhen-long Zhu; Wan-zheng Qi; Zhong-li Shi
Journal:  Zhongguo Ying Yong Sheng Li Xue Za Zhi       Date:  2010-02

4.  Carbon monoxide liberated from CO-releasing molecule (CORM-2) attenuates ischemia/reperfusion (I/R)-induced inflammation in the small intestine.

Authors:  Kazuhiro Katada; Aurelia Bihari; Shinjiro Mizuguchi; Norimasa Yoshida; Toshikazu Yoshikawa; Douglas D Fraser; Richard F Potter; Gediminas Cepinskas
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

Review 5.  Complement inhibition as a proposed neuroprotective strategy following cardiac arrest.

Authors:  Brad E Zacharia; Zachary L Hickman; Bartosz T Grobelny; Peter A DeRosa; Andrew F Ducruet; E Sander Connolly
Journal:  Mediators Inflamm       Date:  2010-01-26       Impact factor: 4.711

6.  Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease.

Authors:  D S Sheps; M C Herbst; A L Hinderliter; K F Adams; L G Ekelund; J J O'Neil; G M Goldstein; P A Bromberg; J L Dalton; M N Ballenger
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

7.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.

Authors:  Stephen A Bernard; Timothy W Gray; Michael D Buist; Bruce M Jones; William Silvester; Geoff Gutteridge; Karen Smith
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

8.  A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells.

Authors:  Ignazio Barbagallo; Daniele Tibullo; Michelino Di Rosa; Cesarina Giallongo; Giuseppe A Palumbo; Giuseppina Raciti; Agata Campisi; Angelo Vanella; Colin J Green; Roberto Motterlini
Journal:  J Neurosci Res       Date:  2008-07       Impact factor: 4.164

Review 9.  Heme oxygenase-1/carbon monoxide: from metabolism to molecular therapy.

Authors:  Stefan W Ryter; Augustine M K Choi
Journal:  Am J Respir Cell Mol Biol       Date:  2009-07-17       Impact factor: 6.914

10.  Short-term effects of carbon monoxide exposure on the exercise performance of subjects with coronary artery disease.

Authors:  E N Allred; E R Bleecker; B R Chaitman; T E Dahms; S O Gottlieb; J D Hackney; M Pagano; R H Selvester; S M Walden; J Warren
Journal:  N Engl J Med       Date:  1989-11-23       Impact factor: 91.245

View more
  1 in total

1.  Carboxyhemoglobin Does Not Predict the Need of Mechanical Ventilation and Prognosis during COPD Exacerbation.

Authors:  Shimon Izhakian; Eitan Harper; Oleg Gorelik; Assaf Frajman; Ori Mekiten; Adina Bar-Chaim; Mordechai Reuven Kramer
Journal:  Can Respir J       Date:  2022-04-16       Impact factor: 2.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.